Abstract
Accurate identification and classification of bone marrow (BM) nucleated cell morphology are crucial for the diagnosis of hematological diseases. However, the subjective and time-consuming nature of manual identification by pathologists hinders prompt diagnosis and patient treatment. To address this issue, we developed Morphogo, a convolutional neural network-based system for morphological examination. Morphogo was trained using a vast dataset of over 2.8 million BM nucleated cell images. Its performance was evaluated using 508 BM cases that were categorized into five groups based on the degree of morphological abnormalities, comprising a total of 385,207 BM nucleated cells. The results demonstrated Morphogo’s ability to identify over 25 different types of BM nucleated cells, achieving a sensitivity of 80.95%, specificity of 99.48%, positive predictive value of 76.49%, negative predictive value of 99.44%, and an overall accuracy of 99.01%. In most groups, Morphogo cell analysis and Pathologists' proofreading showed high intragroup correlation coefficients for granulocytes, erythrocytes, lymphocytes, monocytes, and plasma cells. These findings further validate the practical applicability of the Morphogo system in clinical practice and emphasize its value in assisting pathologists in diagnosing blood disorders.
Subject terms: Cancer, Diseases, Engineering
Introduction
The morphological examination of bone marrow (BM) nucleated cells plays a crucial role in the diagnosis of various hematological diseases, including acute leukemia (AL), chronic leukemia (CL), myelodysplastic syndrome (MDS), plasma cell myeloma (PCM), and hemorrhagic disease. It is considered one of the most critical diagnostic procedures, alongside immunological diagnosis and cytogenetics diagnosis according to the diagnostic guidelines of hematopoietic cancers issued by the World Health Organization (WHO)1–6. Typically, BM morphology assessment involves skilled technicians performing a differential count followed by verification and diagnosis by experienced hematopathologists. However, this process heavily relies on the expertise of technicians and pathologists and is time-consuming, which limits the overall efficiency of BM assessment7–9. Therefore, there is a pressing need for an automated approach to conducting standardized BM cell differential counts.
A convolution neural network (CNN) is a kind of feedforward neural network that consists of convolution computation and depth structure10. CNNs, being representative algorithms of deep learning, have gained widespread usage in computer-aided systems11. Their exceptional ability to extract image features was showcased when CNNs achieved top performance in the ImageNet 2012 competition. Since then, numerous studies have concentrated on CNN development and its application in clinical settings, to reduce the workload of medical professionals in object recognition and image classification and improve the precision of clinical diagnosis8,12–14. Automated pathology analysis systems developed based on CNN models are mainly used for histopathology and peripheral blood morphology, and there are fewer reports on the identification of BM nucleated cells until the last five years when they have been rapidly developed 14–17. By combining CNN and Gabor, Huang et al. created the innovative MGCNN framework for classifying blood cells. In comparison to conventional CNNs, this unique approach significantly increases classification accuracy but comes at a higher computational cost18. Liu et al. were able to analyze 200 fields in 16 min using a faster Region-Convolutional Neural Network (R-CNN) for BM imaging cell detection, taking an average of 4.8 s per image and achieving an accuracy of 0.496. However, the microscope's focus had to be manually adjusted throughout the observation to maintain a clear field of view19. Eckardt et al. used a multi-step deep learning methodology to separate cells from pictures of BM to discriminate between acute myeloid leukemia (AML) and healthy cells and to forecast the state of the Nucleophosmin 1 (NPM1) mutation, the most prevalent mutation in AML. However, this system requires the manual selection of areas for disease classification as judged by the pathologist, making the results potentially erroneous20. To detect acute lymphoblastic leukemia (ALL) in microscopic blood pictures, Atteia et al. are optimized using the Bayesian optimization technique. On a holdout test set, the best CNN model determined by the Bayesian optimization approach for ALL detection recorded 100% accuracy, specificity, and sensitivity21.
The Morphogo system we have developed overcomes many of these limitations, enabling efficient and accurate identification and classification of BM nucleated cells. According to our previous research, The Morphogo system integrates digital imaging of BM smear with artificial intelligence-based automatic BM cell differential count and has shown high accuracies in identifying various cell types, including granulocytic cells, erythroid cells, lymphoid cells, plasma cells, and monocytic cells, and even metastatic cancer cells6,8,22,23. We are committed to further improving the Morphogo system to enhance its performance and clinical value in assisting with the diagnosis of hematologic diseases.
Methods
Sources and classification of samples
This was a retrospective study. 508 BM cases were collected from Kingmed Diagnostics from October 2021 to December 2021. Following the recommendations of pathologists, the BM smears were divided into five groups, denoted G1–G5, based on the extent of pathological and cell morphological changes. The diseases grouped within each category are as follows: G1: Relatively normal cases; G2: Disorders with quantitative abnormalities primarily affecting mature cells, including anemia, bleeding/thrombosis, myeloproliferative neoplasms (MPN), chronic myeloid leukemia (CML); G3: Disorder follow-up cases; G4: Malignant hematological disorders characterized by a substantial proliferation of blasts and immature cells, including acute leukemia (AL), Multiple myeloma (MM); G5: Disorders associated with a higher occurrence of abnormal cells, including megaloblastic anemia (MgA), myelodysplastic syndrome (MDS), Chronic lymphoproliferative disease (CLPD). All BM smears underwent appropriate staining using the Wright-Giemsa method, ensuring the quality aligned with the recommendation of the nation guide to clinical laboratory procedures (NGCLP, fourth edition) or the international council for Standardization in Hematology (ISH)8. The study was approved by the Ethics Committee of Guangzhou Kingland Medical Laboratory Center. The detailed information of the enrolled BM cases was listed in Table 1.
Table 1.
Grouping and basic information of BM smear samples.
| Group | Sample | Number |
|---|---|---|
| G1 | Relatively Normal | 111 |
| G2 | Anemia | 33 |
| Bleeding/Thrombosis | 26 | |
| MPN | 11 | |
| CML | 11 | |
| Others | 17 | |
| G3 | Disorder Follow-up | 152 |
| G4 | AL | 60 |
| MM | 39 | |
| Others | 1 | |
| G5 | MgA | 6 |
| MDS | 18 | |
| CLPD | 12 | |
| Others | 11 |
MPN myeloproliferative neoplasms, CML chronic myeloid leukemia, AL acute leukemia, MM multiple myeloma, MgA megaloblastic anemia, MDS myelodysplastic syndrome, CLPD chronic lymphoproliferative disease.
System workflow
Morphogo system is a CNN-based Artificial Intelligence (AI) system developed by Hangzhou Zhiwei Information and Technology Ltd that is used to perform a differential count of BM nucleated cells automatically.
The workflow is as follows: (1) The Morphogo system initiates an automated scan of the BM smear using a 40 × objective lens, capturing a whole slide image (WSI) in the process. This enables the system to count megakaryocytes and identify the adaptive area for cell analysis. (2) Subsequently, the system switches to a 100 × objective lens to capture images of the designated area. Using CNN, the system identifies BM nucleated cells within this area and performs a differential cell count until a specified number of cells are obtained. (3) Before finalizing and releasing the cell morphology report, the data undergoes review by a pathologist. (Fig. 1).
Figure 1.
Workflow design for Morphogo analysis and pathologist review.
Morphogo system evaluation
To evaluate the cell classification performance of the Morphogo system in different hematological diseases, the BM nucleated cells were categorized into 25 categories: proerythroblast, early erythroblast, intermediate erythroblast, late erythroblast, myeloblast, promyelocyte, neutrophilic myelocyte, neutrophilic metamyelocyte, band neutrophil, segmented neutrophil, eosinophilic myelocyte, eosinophilic metamyelocyte, band eosinophil, segmented eosinophil, basophil, monoblast, promonocyte, monocyte, lymphoblast, prolymphocyte, mature lymphocyte, plasmablast, immature plasma, plasma cell and others including smudge cell, histocyte, and mast cell according to WHO classification. Cell classification performance was evaluated in terms of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy14,24. Accurately identifying individual morphological categories can be challenging, particularly when closely related categories exhibit morphological similarities. Recognizing this uncertainty in the morphological identification of BM nucleated cells, we incorporate the concept of tolerance classes, wherein certain mispredictions by the CNN model are deemed acceptable even if they differ from the precise labels provided by pathologists. This consideration was called tolerance classes25. The presence of tolerance classes is illustrated in Fig. 2, where the light blue color indicates tolerable mix-ups. For example, the confusion between myelocyte and promonocyte falls within the realm of tolerance. furthermore, we collected and compared the results of pathologists’ proofreading of all BM smears with the output of the Morphogo system, using kappa values as a metric to assess the agreement between the two approaches in disease diagnosis.
Figure 2.
The summary of cell classification results obtained by Morphogo pre-classification and pathologists’ proofreading. The confusion matrix displays the count of cell images within each of the 25 morphological categories of BM nucleated cells. Rows represent the preliminary classifications by the Morphogo system, while columns reflect the pathologists' review. Diagonal entries in the matrix indicate the instances where the Morphogo system's classification aligns with the pathologists' review. Mix-ups that are considered tolerable are highlighted in light blue.
Establishment of algorithms
In the process of Morphogo scanning and analyzing BM smears, intelligent algorithms play an important role. There are several key algorithms involved in this process. The first is the slide scanning area algorithm, which extracts the slide area to be observed by mimicking the human task-based visual object attention mechanism to determine the 40 × scanning coverage. The second is the auto-focal plane algorithm. When the camera rapidly captures more than 100 images with varying sharpness at different object distances, the Sobel operator is applied to extract the gradient values in different directions of the images. By quantifying image clarity using a dedicated function, the algorithm identifies the clearest regions within each image and an image fusion algorithm is then employed to merge these regions, ensuring the best clarity for every nucleated cell within the field of view.
Then, the 40 × full-slide assembling algorithm is utilized to introduce feature changes while maintaining a consistent scale, and the key points of the image are identified by the Gaussian differential function, and the key points are matched based on Ransac algorithm, achieving seamless assembly of the image and generating a WSI. Once the WSI is obtained, an area selection algorithm is used to select an optimal area for 100 × cell imaging. In 100 × cell images, a cell segmentation method based on saturation clustering is employed to accurately separate and locate the nucleated cells for differential count. Finally, the classification of BM nucleated cells is realized by a deep learning algorithm. This algorithm utilizes expert-labeled cell images and incorporates different types of cell morphological characteristics. By leveraging and the updated big data platform, which provides a continually expanding dataset, the algorithm achieves accurate classification and analysis of BM nucleated cells.
Training of algorithm
The Morphogo system, which has been trained by more than 2.8 million BM nucleated cells, has now developed and refined to the point where it can automatically scan and analyze BM smears in less than 10 min while detecting more than 35 different types of nucleated cells (Table 2). The training of the algorithm was run on a server equipped with Intel Core i9 10, 900X, 16G × 4 ADATA DDR4, NVIDIA GeForce RTX 2080 Ti cards, and CUDA Version 10.2. The optimal algorithm for cell categorization was obtained after several training sessions. Subsequently, 385,207 BM cell images in this paper were used as validation datasets.
Table 2.
Classes of BM cells pre-classified by Morphogo.
| Number | Class of Cells |
|---|---|
| 1 | Myeloblast |
| 2 | Promyelocyte |
| 3 | Neutrophilic myelocyte |
| 4 | Neutrophilic metamyelocyte |
| 5 | Band neutrophil |
| 6 | Segmented neutrophil |
| 7 | Eosinophilic myelocyte |
| 8 | Eosinophilic metamyelocyte |
| 9 | Band eosinophil |
| 10 | Segmented eosinophil |
| 11 | Basophil |
| 12 | Proerythroblast |
| 13 | Early erythroblast |
| 14 | Intermediate erythroblast |
| 15 | Late erythroblast |
| 16 | Megaloblastic early erythroblast |
| 17 | Megaloblastic intermediate erythroblast |
| 18 | Megaloblastic late erythroblast |
| 19 | Lymphoblast |
| 20 | Prolymphocyte |
| 21 | Mature lymphocyte |
| 22 | Atypical lymphocyte |
| 23 | Monoblast |
| 24 | Promonocyte |
| 25 | Monocyte |
| 26 | Plasmablast |
| 27 | Immature plasma cell |
| 28 | Plasma cell |
| 29 | Histocyte |
| 30 | Smudge cell |
| 31 | Phagocyte |
| 32 | Mast cell |
| 33 | Erythrocyte |
| 34 | Mitosis |
| 35 | Platelet |
Statistical analysis and interpretation
Excel version 2016 was used to analyze the sensitivity, specificity, PPV, NPV, and accuracy of Morphogo’s cell classification by assuming pathologists’ annotations as the absolute true cell classification. The correlations of cell proportions were plotted by GraphPad Prism 7.0. Kappa and ICC for two different methods were performed by IBM SPSS Statistics 20 to evaluate the consistency. To interpret the correlation, the r-value is as follows: r less than 0.09 was no correlation; 0.1–0.3 was a weak correlation; 0.3–0.5 a was a moderate correlation. 0.5–1.0 was a high correlation26. The relationship between K value and consistency is as follows: K = 0–0.20, extremely weak consistent; K = 0.21–0.40, weak consistent; K = 0.41–0.60, moderately consistent; K = 0.61–0.80, strongly consistent, and K = 0.81–1.0, almost perfect consistent27. Unless otherwise indicated, all data were displayed as mean and standard deviation (x̅ ± s) and analyzed by two-tailed Student’s t-test. p < 0.05 were considered statistically significant differences.
Statement
All of the above methods were performed by the relevant guidelines and regulations.
Ethical approval
This study was approved by the Ethics Committee of Guangzhou Kingmed Diagnostics Medical Laboratory Center. Because abandoned samples of routine clinical detections were collected and clinical case information was used, the Ethics Committee of Guangzhou Kingmed Diagnostics Medical Laboratory Center therefore has approved the application for performing the study with the exemption of informed consent from all participants.
Results
Highly accurate classification of BM nucleated cells by Morphogo system
The high-resolution digital images of BM nucleated cells from the ROI were acquired using the Morphogo system. These cell images were categorized into 25 categories (Fig. 3). Cell classification results predicted by the Morphogo system and annotated by pathologists were shown in a confusion matrix (Fig. 2). The dataset consisted of 385,207 single-cell images. The row displayed cell classification results from the Morphogo system, and the column showed results from pathologists’ proofreading. The dark blue pane located diagonally illustrated the number of nucleated cells classified by the Morphogo system which were entirely consistent with pathologists’ proofreading. The white pane represented cells that were classified as different types by the Morphogo system and pathologists proofreading. Cell numbers shown in light blue panes represented cells that were easily confused either between different maturing stages within the same lineage or between morphologically related cell types, so their misclassification was considered tolerable.
Figure 3.
Sample images of BM cells classified by Morphogo.
To evaluate the cell classification performance of the Morphogo system under different pathological conditions, the Morphogo system was applied to patient cases with more than 14 types of hematological diseases. The evaluation indicators were calculated for each disease condition and are shown in Table 3. The sensitivity in the classification of BM nucleated cells by the Morphogo system was an average value of 80.95%. The Morphogo system exhibited a sensitivity of more than 95% in the identification of 9 categories of BM nucleated cells. For specificity, the test sample yielded an average of 99.48% for all classes of BM nucleated cells. The value of PPV varied greatly in different classes of BM nucleated cells, ranging from 30.45% to 99.69%, with an average value of 76.49%. The Morphogo system showed a more than 95% PPV value among Neutrophilic metamyelocytes, Band neutrophils, Segmented neutrophils, Intermediate erythroblasts, Monocytes, and others. The average value of the NPV was more than 99%, ranging from 95.43 to 100.00%. And the NPVs of eosinophilic metamyelocyte, band eosinophil, and plasmablast ahead of the other cells have a value of 100.00%. The Morphogo system performed a high accuracy in the classification of BM nucleated cells by 95.55–99.98%, with an average value of 99.01%. Therefore, the results of our study showed that the Morphogo system had high sensitivity, specificity, PPV, NPV, and accuracy in the classification and counting of BM nucleated cells.
Table 3.
Performance of Morphogo system to classify BM nucleated cells.
| Class of Cells | Number of Cells | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Accuracy (%) |
|---|---|---|---|---|---|---|
| Myeloblast | 6663 | 65.65 | 98.83 | 49.75 | 99.39 | 98.26 |
| Promyelocyte | 6261 | 87.88 | 96.97 | 32.40 | 99.79 | 96.82 |
| Neutrophilic myelocyte | 22,030 | 73.74 | 99.50 | 89.93 | 98.42 | 98.03 |
| Neutrophilic metamyelocyte | 22,154 | 85.92 | 99.78 | 95.93 | 99.15 | 98.98 |
| Band neutrophil | 35,968 | 98.48 | 99.66 | 96.73 | 99.84 | 99.55 |
| Segmented neutrophil | 49,027 | 98.99 | 99.81 | 98.71 | 99.85 | 99.71 |
| Eosinophilic myelocyte | 862 | 97.56 | 99.93 | 76.87 | 99.99 | 99.93 |
| Eosinophilic metamyelocyte | 1766 | 99.77 | 99.85 | 75.43 | 100.00 | 99.85 |
| Band eosinophil | 1247 | 99.52 | 99.92 | 79.70 | 100.00 | 99.92 |
| Segmented eosinophil | 2141 | 98.74 | 99.96 | 92.84 | 99.99 | 99.95 |
| Basophil | 973 | 79.45 | 99.96 | 83.93 | 99.95 | 99.91 |
| Proerythroblast | 236 | 81.36 | 99.96 | 54.70 | 99.99 | 99.95 |
| Early erythroblast | 2949 | 86.64 | 99.84 | 80.55 | 99.90 | 99.74 |
| Intermediate erythroblast | 18,278 | 95.04 | 99.87 | 97.37 | 99.75 | 99.64 |
| Late erythroblast | 40,030 | 98.01 | 98.96 | 91.58 | 99.77 | 98.86 |
| Lymphoblast | 2626 | 59.41 | 99.58 | 49.46 | 99.72 | 99.31 |
| Prolymphocyte | 7589 | 65.44 | 98.02 | 39.86 | 99.30 | 97.37 |
| Mature lymphocyte | 52,295 | 85.01 | 97.21 | 82.70 | 97.64 | 95.55 |
| Monoblast | 1786 | 59.35 | 99.77 | 54.39 | 99.81 | 99.58 |
| Promonocyte | 3016 | 8.99 | 99.84 | 30.45 | 99.29 | 99.13 |
| Monocyte | 7717 | 82.32 | 99.94 | 96.43 | 99.64 | 99.58 |
| Plasmablast | 1429 | 100.00 | 99.98 | 93.77 | 100.00 | 99.98 |
| Immature plasma | 2637 | 37.05 | 99.91 | 74.64 | 99.57 | 99.48 |
| Plasma cell | 4166 | 94.74 | 99.94 | 94.45 | 99.94 | 99.88 |
| Others | 91,361 | 84.62 | 99.92 | 99.69 | 95.43 | 96.29 |
Sensitivity = TP/(TP + FN) * 100%; Specificity = TN/(TN + FP) * 100%; PPV = TP/(TP + FP) * 100%.
NPV = TN/(FN + TN) * 100%; Accuracy = (TP + TN)/(TP + FP + TN + FN) *100%.
TP true positive, TN true negative, FP false positive, FN false negative.
Morphogo system was in substantial agreement with pathologists’ proofreading in the identification of BM nucleated cells
To better understand the agreement of BM nucleated cells between the Morphogo system and pathologists proofreading, we performed the correlation analysis and consistency analysis between the Morphogo system and pathologists proofreading in the classification and counting of BM nucleated cells. The results were shown in Fig. 4. Morphogo system showed positive correlation between pathologists and Morphogo system in the classification of myeloblast (r = 0.6009, Fig. 4A), promyelocyte (r = 0.8008, Fig. 4B), neutrophilic myelocyte (r = 0.8912, Fig. 4C), neutrophilic metamyelocyte (r = 0.8954, Fig. 4D), band neutrophil (r = 0.9923, Fig. 4E), segmented neutrophil (r = 0.9982, Fig. 4F), eosinophilic myelocyte (r = 0.8039, Fig. 4G), eosinophilic metamyelocyte (r = 0.8691, Fig. 4H), band eosinophil (r = 0.8134, Fig. 4I), segmented eosinophil (r = 0.9878, Fig. 4J), basophil (r = 0.9204, Fig. 4K), proerythroblast (r = 0.6903, Fig. 4L), early erythroblast (r = 0.8878, Fig. 4M), intermediate erythroblast (r = 0.9817, Fig. 4N), late erythroblast (r = 0.9930, Fig. 4O), lymphoblast (r = 0.7923, Fig. 4P), prolymphocyte (r = 0.7724, Fig. 4Q), mature lymphocyte (r = 0.7785, Fig. 4R), monoblast (r = 0.7071, Fig. 4S), promonocyte (r = 0.2038, Fig. 4T), monocyte (r = 0.9489, Fig. 4U), plasmablast (r = 0.9985, Fig. 4V), immature plasma cell (r = 0.5702, Fig. 4W), plasma cell (r = 0.9963, Fig. 4X) and others (r = 0.9695, Fig. 4Y), the P values of these 25 classes of BM nucleated cells were less than 0.001.
Figure 4.
The correlation analysis of Morphogo pre-classification and pathologists’ proofreading. (A)–(Y) shows the scatter plot of linear regression lines of the percentage of BM cells after paired counting of BM smears in 508 patients.
It was shown that the cell classification results of the Morphogo system were in general agreement with that of pathologists proofreading in the identification of BM nucleated cells, as evidenced by kappa value (0.461–0.987), except for promonocytes (Table 4). The Morphogo system exhibited almost perfect agreement with pathologists’ proofreading in the classification of neutrophilic metamyelocyte, band neutrophil, segmented neutrophil, eosinophilic myelocyte, eosinophilic metamyelocyte, band eosinophil, segmented eosinophil, basophil, early erythroblast, intermediate erythroblast, late erythroblast, mature lymphocyte, monocyte, plasmablast, plasma cell, and others, with the kappa value of more than 0.813. However, the classification of myeloblast, promyelocyte, lymphoblast, prolymphocyte, monoblast, and immature plasma showed only moderate agreement between the Morphogo system and pathologists’ proofreading, with Kappa value from 0.461 to 0.566. Overall, correlation and consistency results collectively supported that the Morphogo system maintained a substantial agreement with pathologists’ proofreading in identifying BM nucleated cells.
Table 4.
Evaluation of the consistency between Morphogo pre-classification and pathologists’ proofreading of BM cells using the Cohen kappa coefficient.
| Class of Cells | Kappa | P value |
|---|---|---|
| Myeloblast | 0.557 | 0.000 |
| Promyelocyte | 0.461 | 0.000 |
| Neutrophilic myelocyte | 0.800 | 0.000 |
| Neutrophilic metamyelocyte | 0.901 | 0.000 |
| Band neutrophil | 0.973 | 0.000 |
| Segmented neutrophil | 0.987 | 0.000 |
| Eosinophilic myelocyte | 0.860 | 0.000 |
| Eosinophilic metamyelocyte | 0.858 | 0.000 |
| Band eosinophil | 0.885 | 0.000 |
| Segmented eosinophil | 0.957 | 0.000 |
| Basophil | 0.816 | 0.000 |
| Proerythroblast | 0.654 | 0.000 |
| Early erythroblast | 0.834 | 0.000 |
| Intermediate erythroblast | 0.960 | 0.000 |
| Late erythroblast | 0.940 | 0.000 |
| Lymphoblast | 0.536 | 0.000 |
| Prolymphocyte | 0.483 | 0.000 |
| Mature lymphocyte | 0.813 | 0.000 |
| Monoblast | 0.566 | 0.000 |
| Promonocyte | 0.136 | 0.000 |
| Monocyte | 0.886 | 0.000 |
| Plasmablast | 0.968 | 0.000 |
| Immature plasma | 0.493 | 0.000 |
| Plasma cell | 0.945 | 0.000 |
| Others | 0.892 | 0.000 |
The Morphogo system has high application value in the diagnosis of hematological diseases
To further verify the application value of the Morphogo system in the diagnosis of hematological diseases, the diagnoses made based on the Morphogo system were compared to the pathologists proofreading. The evaluation was made for each sample group (G1–G5) in terms of intraclass correlation coefficient (ICC) and 95% CI. As shown in Table 5, except for the progenitors, ICC between the two different methods was high for granulocytes, erythrocytes, lymphocytes, monocytes, and plasma cells in the G1, G2, G3, and G5 groups (ICC ≥ 0.818, P < 0.01), and slightly lower for G4. Based on these results, the diagnosis results of the Morphogo system for most hematological diseases should be correct.
Table 5.
Correlation analysis between Morphogo and manual proofreading among 5 groups (ICC and 95% CI).
| Cell Series | G1 | G2 | G3 | G4 | G5 |
|---|---|---|---|---|---|
| Blasts |
0.083 (− 0.104–0.265) |
0.593 (0.992–0.996) |
0.216 (0.060–0.363) |
0.835 (0.764–0.886) |
0.203 (− 0.086–0.461) |
| Granulocytes |
0.995 (0.992–0.996) |
0.998 (0.997–0.998) |
0.995 (0.994–0.997) |
0.855 (0.791–0.900) |
0.996 (0.992–0.998) |
| Erythroblasts |
0.996 (0.994–0.997) |
0.989 (0.984–0.993) |
0.996 (0.995–0.997) |
0.995 (0.993–0.997) |
0.989 (0.980–0.994) |
| Lymphocytes |
0.956 (0.937–0.970) |
0.893 (0.844–0.927) |
0.912 (0.880–0.935) |
0.531 (0.374–0.658) |
0.831 (0.715–0.902) |
| Monocytes |
0.944 (0.919–0.961) |
0.818 (0.740–0.874) |
0.980 (0.972–0.985) |
0.815 (0.737–0.871) |
0.945 (0.903–0.969) |
| Plasma cells |
0.943 (0.918–0.961) |
0.992 (0.988–0.995) |
0.998 (0.997–0.998) |
0.826 (0.752–0.880) |
0.896 (0.820–0.941) |
ICC intraclass correlation coefficient.
The Morphogo system automatically records the time it takes to scan BM smears and identify BM cells
Morphogo system can complete automatic scanning continuously, and efficiently, with a success rate of 99.4%. The average time of a single slide scan is 7:46 (min), and most of the slide scanning time is concentrated in 5–9 min. The Morphogo system takes 7.46 ± 0.002 min/sheet to identify and count BM cells (Table 6). These results suggest that the Morphogo system can assist in the artificial diagnosis of hematologic diseases, which greatly saves time.
Table 6.
The time required for Morphogo to scan a digital BM slide and count 600 nucleated cells.
| Method | Time (min) |
|---|---|
| Morphogo | 7.46 ± 0.002 |
Discussion
One of the most challenging steps in the workup of diagnosis of blood diseases is the morphological classification of BM nucleated cells, and the effectiveness of the classifier determines its utility in blood disorder diagnostics. CNN models, currently the leading classification framework, have shown superior performance compared to manual cellular morphological feature detection 8,25,28 in recognizing and classifying diverse medical images. Our results, obtained using Morphogo, a cell morphology analysis system created using CNN models, indicate that rapid advancements in artificial intelligence will enable automated hematologic disease screening systems to realize their full potential.
To enhance the CNN’s ability to discern potential relationships between BM nucleated cells during the learning process, we trained the CNN on the discriminative features of BM nucleated cells using 2.3 million BM cell images. We then tested the trained model on over 0.5 million cell images collected from various hospitals. This extensive database is beyond the reach of most models. The Morphogo system can now identify more than 35 classes of BM nucleated cells, including certain pathological cell types, and a few non-hematopoietic cells. Our results showed that the Morphogo system achieves high sensitivity, specificity, PPV, NPV, and accuracy in the classification and counting of 25 classes of BM nucleated cells. Moreover, the Morphogo system’s cell differential results were in substantial agreement with those of pathologists’ proofreading. Furthermore, the Morphogo system has the capability to automatically scan, identify and count BM nucleated cells, with an average processing time of 7.46 min. This indicates a substantial potential for the Morphogo system to enhance the efficiency of BM cell morphology analysis.
The study provided pathologists with a potential application of AI in the morphology examination of BM smears. However, as previous research has reported, even experienced pathologists find it challenging to identify small differences between cells with similar morphological characteristics are difficult to identify25. For example, a promonocyte is often misidentified as a monocyte. Both manual counting and smart counting are affected by staining differences, and increasing the training data does not significantly improve accuracy29. The current Morphogo system cannot accurately distinguish subtle differences between morphologically similar cells. This limitation may explain why the sensitivity and PPV performance were not satisfactory in the identification of promonocytes. Furthermore, the image quality of BM nucleated cells depends on several factors such as the quality of BM smear preparation, the pathological condition, and the imaging process13. These factors can contribute to inaccuracies in BM cell identification. The morphology of blasts in AL of G4 is more uniform, while in MDS of G5, blasts tend to be polymorphic and malformed13. Consequently, blasts are easier to be identified and classified in AL, and difficult to be identified in MDS, which might be the cause of the higher misdiagnosis rate in some cases when using the Morphogo system compared to pathologists’ manual review. However, due to the large number of BM samples processed daily and the laborious and time-consuming nature of BM cell differential counting, some laboratories only count 100–200 cells in each BM smear. By utilizing the Morphogo system, they can review AI-based cell differential count results on a computer screen, dramatically improving the efficiency of laboratory work. The Morphogo system can analyze a larger number of cells in a shorter time, allowing pathologists to review more cells and avoid misdiagnosing critical morphological changes, ultimately reducing the misdiagnosis rate. Furthermore, the Morphogo system provides a standardized and digital approach to cell differential counting, enabling more reliable and repeatable assessment of morphology, and enhancing the overall quality control of BM morphology assessment. It also facilitates better comparison and communication among technicians and pathologists, ultimately leading to more effective patient care.
This study employed a single-center method, where all BM smears were prepared in the same laboratory and digitally processed. The performance evaluation of the Morphogo system focused on identifying BM nucleated cells in common hemato-pathological conditions, and the dataset reasonably reflects the morphological changes of most cell types. However, this study still had some limitations. Firstly, it was limited to 14 common diseases, and the number of cases was insufficient to determine whether the Morphogo system’s AI performance would be consistent across all common hematopathological diseases and rare conditions. Secondly, efforts should be made to minimize the impact of staining variations on categorization strategies. Last but not least, we did not specifically collect samples of cells with dysplastic abnormalities during the initial development of the algorithm, serving as a training sample. As a result, when performing the statistical analysis, we discovered that the quantities of various types of qualitative cellular changes were not sufficient. In the future, further studies should be conducted using a larger number of BM samples that encompass a broader range of hematological diseases from multiple laboratories. This would help to further validate the BM cell identification performance of the Morphogo system more comprehensively.
Conclusion
CNN-based Morphogo system could classify and count BM nucleated cells to assist pathologists to diagnose hematological diseases. The Morphogo system is a potential digital analysis system that provides a more objective and efficient method for BM morphology assessment.
Supplementary Information
Acknowledgements
The authors would like to acknowledge the technical help provided by Junlin Feng and Zhen Huang in constructing the CNN algorithm model.
Author contributions
Z.L. designed the study, and cell annotation, and managed the progress of the study as well as the quality of the manuscript. X.C. helped in experimental design, data analysis, manuscript writing and revision, and preparation of submission materials. X.J. made constructive suggestions and participated in the revision of the article, supplemented the article framework and content, and added important references. S.X. and H.D. assisted in sample acquisition and cell annotation. All authors contributed to the article and approved the submitted version.
Data availability
All data generated or analyzed during this study are included in this manuscript and supplementary information files.
Competing interests
XC and XJ are employed by Hangzhou Zhiwei Information Technology Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-023-40424-x.
References
- 1.Huang F, Guang P, Li F, Liu X, Zhang W, Huang W. AML, ALL, and CML classification and diagnosis based on bone marrow cell morphology combined with convolutional neural network: A STARD compliant diagnosis research. Med. (Baltim.) 2020;99:e23154. doi: 10.1097/MD.0000000000023154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Elsabah H, et al. Plasma cell myeloma with an aggressive clinical course and anaplastic morphology in a 22-year-old patient: A case report and review of literature. Am. J. Case Rep. 2020;21:e920489. doi: 10.12659/AJCR.920489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Dasariraju S, Huo M, McCalla S. Detection and classification of immature leukocytes for diagnosis of acute myeloid leukemia using random forest algorithm. Bioeng. (Basel) 2020;7:120. doi: 10.3390/bioengineering7040120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bain BJ, Béné MC. Morphological and immunophenotypic clues to the WHO categories of acute myeloid leukaemia. Acta Haematol. 2019;141:232–244. doi: 10.1159/000496097. [DOI] [PubMed] [Google Scholar]
- 5.Wang SA, et al. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified, and reactive idiopathic hypereosinophilic syndrome. Haematologica. 2017;102:1352–1360. doi: 10.3324/haematol.2017.165340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Fu X, et al. Morphogo: An automatic bone marrow cell classification system on digital images analyzed by artificial intelligence. Acta Cytol. 2020;64:588–596. doi: 10.1159/000509524. [DOI] [PubMed] [Google Scholar]
- 7.Gisslinger H, et al. Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: Comparison between the BCSH and the WHO criteria. Leukemia. 2017;31:774–775. doi: 10.1038/leu.2016.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Chen P, et al. Detection of metastatic tumor cells in the bone marrow aspirate smears by artificial intelligence (AI)-based morphogo system. Front Oncol. 2021;11:742395. doi: 10.3389/fonc.2021.742395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Su J, Liu S, Song J. A segmentation method based on HMRF for the aided diagnosis of acute myeloid leukemia. Comput. Methods Prog. Biomed. 2017;152:115–123. doi: 10.1016/j.cmpb.2017.09.011. [DOI] [PubMed] [Google Scholar]
- 10.Chumachenko K, Iosifidis A, Gabbouj M. Feedforward neural networks initialization based on discriminant learning. Neural Netw. 2022;146:220–229. doi: 10.1016/j.neunet.2021.11.020. [DOI] [PubMed] [Google Scholar]
- 11.Shafique S, Tehsin S. Computer-aided diagnosis of acute lymphoblastic leukaemia. Comput. Math. Methods Med. 2018;2018:6125289. doi: 10.1155/2018/6125289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ehteshami Bejnordi B, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA. 2017;318:2199–2210. doi: 10.1001/jama.2017.14585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wu YY, et al. A hematologist-level deep learning algorithm (BMSNet) for assessing the morphologies of single nuclear balls in bone marrow smears: Algorithm development. JMIR Med. Inform. 2020;8:e15963. doi: 10.2196/15963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Esteva A, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542:115–118. doi: 10.1038/nature21056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Pattarone G, Acion L, Simian M, Mertelsmann R, Follo M, Iarussi E. Learning deep features for dead and living breast cancer cell classification without staining. Sci. Rep. 2021;11:10304. doi: 10.1038/s41598-021-89895-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Tavakoli S, Ghaffari A, Kouzehkanan ZM, Hosseini R. New segmentation and feature extraction algorithm for classification of white blood cells in peripheral smear images. Sci. Rep. 2021;11:19428. doi: 10.1038/s41598-021-98599-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Albarqouni S, Baur C, Achilles F, Belagiannis V, Demirci S, Navab N. AggNet: Deep learning from crowds for mitosis detection in breast cancer histology images. IEEE Trans. Med. Imaging. 2016;35:1313–1321. doi: 10.1109/TMI.2016.2528120. [DOI] [PubMed] [Google Scholar]
- 18.Huang Q, Li W, Zhang B, Li Q, Tao R, Lovell NH. Blood cell classification based on hyperspectral imaging with modulated gabor and CNN. IEEE J. Biomed. Health Inform. 2020;24:160–170. doi: 10.1109/JBHI.2019.2905623. [DOI] [PubMed] [Google Scholar]
- 19.Liu J, Yuan R, Li Y, Zhou L, Zhang Z, Yang J, Xiao L. A deep learning method and device for bone marrow imaging cell detection. Ann. Transl. Med. 2022;10:208. doi: 10.21037/atm-22-486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Eckardt JN, Middeke JM, Riechert S, Schmittmann T, Sulaiman AS, et al. Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears. Leukemia. 2022;36:111–118. doi: 10.1038/s41375-021-01408-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Atteia G, Alhussan AA, Samee NA. BO-ALLCNN: Bayesian-based optimized CNN for acute lymphoblastic leukemia detection in microscopic blood smear images. Sensors (Basel) 2022;22:5520. doi: 10.3390/s22155520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Tang G, Fu X, Wang Z, Chen M. A machine learning tool using digital microscopy (Morphogo) for the identification of abnormal lymphocytes in the bone marrow. Acta Cytol. 2021;65:354–357. doi: 10.1159/000518382. [DOI] [PubMed] [Google Scholar]
- 23.Jin H, et al. Developing and preliminary validating an automatic cell classification system for bone marrow smears: A pilot study. J. Med. Syst. 2020;44:184. doi: 10.1007/s10916-020-01654-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Goh KH, et al. Artificial intelligence in sepsis early prediction and diagnosis using unstructured data in healthcare. Nat. Commun. 2021;12:711. doi: 10.1038/s41467-021-20910-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Matek C, Krappe S, Münzenmayer C, Haferlach T, Marr C. Highly accurate differentiation of bone marrow cell morphologies using deep neural networks on a large image data set. Blood. 2021;138:1917–1927. doi: 10.1182/blood.2020010568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Seo MY, Hwang SJ, Nam KJ, Lee SH. Significance of sleep stability using cardiopulmonary coupling in sleep disordered breathing. Laryngoscope. 2020;130:2069–2075. doi: 10.1002/lary.28379. [DOI] [PubMed] [Google Scholar]
- 27.Pereira KN, de Carvalho JAM, Paniz C, Moresco RN, da Silva JEP. Diagnostic characteristics of immature platelet fraction for the assessment of immune thrombocytopenia. Thromb. Res. 2021;202:125–127. doi: 10.1016/j.thromres.2021.03.023. [DOI] [PubMed] [Google Scholar]
- 28.Gulshan V, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 2016;316:2402–2410. doi: 10.1001/jama.2016.17216. [DOI] [PubMed] [Google Scholar]
- 29.Shi J, Wang R, Zheng Y, Jiang Z, Zhang H, Yu L. Cervical cell classification with graph convolutional network. Comput. Methods Programs Biomed. 2021;198:105807. doi: 10.1016/j.cmpb.2020.105807. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data generated or analyzed during this study are included in this manuscript and supplementary information files.